6.4

CVE-2024-5038

Colibri Page Builder <= 1.0.276 - Authenticated (Contributor+) Stored Cross-Site Scripting via Shortcode

Colibri Page Builder <= 1.0.276 - Authenticated (Contributor+) Stored Cross-Site Scripting via Shortcode

The Colibri Page Builder plugin for WordPress is vulnerable to Stored Cross-Site Scripting via the plugin's shortcode(s) in all versions up to, and including, 1.0.276 due to insufficient input sanitization and output escaping on user supplied attributes. This makes it possible for authenticated attackers, with contributor-level access and above, to inject arbitrary web scripts in pages that will execute whenever a user accesses an injected page.
Mögliche Gegenmaßnahme
Colibri Page Builder: Update to version 1.0.277, or a newer patched version
Daten sind bereitgestellt durch National Vulnerability Database (NVD)
ExtendthemesColibri Page Builder SwPlatformwordpress Version < 1.0.277
Weitere Schwachstelleninformationen
SystemWordPress Plugin
Produkt Colibri Page Builder
Version *-1.0.276
Zu dieser CVE wurde keine Warnung gefunden.
EPSS Metriken
Typ Quelle Score Percentile
EPSS FIRST.org 0.32% 0.237
CVSS Metriken
Quelle Base Score Exploit Score Impact Score Vector String
nvd@nist.gov 5.4 2.3 2.7
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N
security@wordfence.com 6.4 3.1 2.7
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:L/A:N
CWE-79 Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting')

The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users.

https://plugins.trac.wordpress.org/browser/colibri-page-builder/trunk/extend-builder/shortcodes/blog/post-item.php#L132
Product
https://plugins.trac.wordpress.org/changeset/3097694/
Patch
https://www.wordfence.com/threat-intel/vulnerabilities/id/08159865-1411-4a07-b5db-f4ba5bf2d633?source=cve
Third Party Advisory
https://www.wordfence.com/threat-intel/vulnerabilities/id/08159865-1411-4a07-b5db-f4ba5bf2d633
Third Party Advisory